Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajplung.00169.2015PMID 26115672PMCID PMC4556932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible Pathogenic Mechanism of Propofol Infusion Syndrome Involves Coenzyme Q

  2015cited by this paper
• The Ratio of 18F-FDG Activity Uptake Between the Right and Left Ventricle in Patients With Pulmonary Hypertension Correlates With the Right Ventricular Function

  2014cited by this paper
• Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.

  2014cited by this paper
• Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension

  2013cited by this paper
• Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.

  2013cited by this paper
• Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension

  2013cited by this paper
• A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension

  2013cited by this paper
• Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle

  2011cited by this paper
• Increased Right Ventricular Glucose Metabolism in Patients With Pulmonary Arterial Hypertension

  2011cited by this paper
• Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension

  2010cited by this paper
• The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle

  2009cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.

  2005cited by this paper
• Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

  2002cited by this paper
• An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001cited by this paper
• Use of [123I]-BMIPP Myocardial Scintigraphy for the Clinical Evaluation of a Fatty-Acid Metabolism Disorder of the Right Ventricle in Chronic Respiratory and Pulmonary Vascular Disease

  2000cited by this paper
• Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course

  1999cited by this paper
• Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle.

  1998cited by this paper
• Comparison of fatty acid tracers FTHA and BMIPP during myocardial ischemia and hypoxia.

  1998cited by this paper
• Detection of impaired fatty acid metabolism in right ventricular hypertrophy: Assessment by I-123 β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography

  1997cited by this paper
• Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

  1997cited by this paper
• 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids.

  1991cited by this paper

• Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension

  2026cites this paper
• Novel Therapies for Right Ventricular Failure

  2025cites this paper
• Roles of Lipid Metabolism in Pulmonary Hypertension: Friend or Foe?

  2025influential citation
• Mitochondrial arginase 2 regulates hematopoietic and cardiovascular adaptation to hypoxia

  2025cites this paper
• From Blood to Vessel: Lipid Ratios in Pulmonary Hypertension

  2025cites this paper
• From Repurposing to Refinement: Optimizing Levofloxacin for Treatment of Multidrug-Resistant Tuberculosis

  2025cites this paper
• Mechanisms and treatment of pulmonary arterial hypertension

  2024cites this paper
• Magnetic nanoradiotracers for targeted neutrophil detection in pulmonary arterial hypertension

  2024cites this paper
• Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats

  2024cites this paper
• Carnitine consumption and effect of oral supplementation in human pulmonary arterial hypertension: A pilot study

  2024cites this paper
• Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension

  2024cites this paper
• Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy

  2023cites this paper
• Chronic hypoxia-induced alterations of the right ventricular myocardium are not aggravated by alimentary obesity in the mouse.

  2023cites this paper
• Pathophysiology and new advances in pulmonary hypertension

  2023cites this paper
• Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension

  2022cites this paper
• Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

  2022cites this paper
• NMR-Based Metabolomic Analysis of Plasma in Patients with Adult Congenital Heart Disease and Associated Pulmonary Arterial Hypertension: A Pilot Study

  2022cites this paper
• Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology

  2022cites this paper
• Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.

  2022cites this paper
• Identification of the Key Pathways and Genes in Hypoxia Pulmonary Arterial Hypertension Following Intrauterine Growth Retardation

  2022cites this paper
• Integrative Omics to Characterize and Classify Pulmonary Vascular Disease.

  2021cites this paper
• Right Ventricular Pathobiology

  2021cites this paper
• Acute Right-Heart Failure in Patients with Chronic Precapillary Pulmonary Hypertension

  2021cites this paper
• Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension

  2021cites this paper
• Disease Specific Platelet Signaling Defects in Idiopathic Pulmonary Arterial Hypertension.

  2021cites this paper
• Metabolism in Pulmonary Hypertension.

  2021cites this paper
• Expression of ApoA5 and its function in the right ventricular failing and remodeling secondary to pulmonary hypertension

  2020influential citation
• Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.

  2020cites this paper
• New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases

  2020cites this paper
• Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension

  2020cites this paper
• Molecular Imaging of the Heart.

  2019cites this paper
• Right Ventricular Size and Function in Chronic Heart Failure: Not to Be Forgotten.

  2019cites this paper
• Human PAH is characterized by a pattern of lipid-related insulin resistance.

  2019cites this paper
• Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update

  2019cites this paper
• OP-EJEC180212 668..676

  2019cites this paper
• Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients

  2019cites this paper
• Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension

  2019cites this paper
• The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension

  2019cites this paper
• Metabolic Remodeling in the Pressure‐Loaded Right Ventricle: Shifts in Glucose and Fatty Acid Metabolism—A Systematic Review and Meta‐Analysis

  2019influential citation
• Metabolic pathways associated with right ventricular adaptation to pulmonary hypertension: 3D analysis of cardiac magnetic resonance imaging

  2018cites this paper
• Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement

  2018cites this paper
• Neuregulin-1 effects in metabolic changes induced by pulmonary arterial hypertension

  2018influential citation
• PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation

  2018cites this paper
• Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018.

  2018cites this paper
• Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography

  2017cites this paper
• Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension

  2017cites this paper
• Assessment of right ventricular metabolism: An emerging tool for monitoring pulmonary artery hypertension

  2017cites this paper
• Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

  2017cites this paper
• Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial.

  2017cites this paper
• The right ventricle and pulmonary hypertension

  2016cites this paper
• [Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016].

  2016cites this paper
• Update on novel targets and potential treatment avenues in pulmonary hypertension.

  2016cites this paper
• Pathobiologie, Pathologie und Genetik der pulmonalen Hypertonie: Empfehlungen der Kölner Konsensus-Konferenz 2016

  2016cites this paper
• Distinct right ventricle remodeling in response to pressure overload in the rat.

  2016cites this paper
• Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability

  2015cites this paper
• Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

  2015cites this paper